GoPro [GPRO] vs Zepp Health [ZEPP] Detailed Stock Comparison

GoPro

Zepp Health
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: GoPro wins in 7 metrics, Zepp Health wins in 11 metrics, with 0 ties. Zepp Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | GoPro | Zepp Health | Better |
---|---|---|---|
P/E Ratio (TTM) | 21.21 | -10.91 | Zepp Health |
Price-to-Book Ratio | 3.34 | 3.56 | GoPro |
Debt-to-Equity Ratio | 126.31 | 47.49 | Zepp Health |
PEG Ratio | -0.31 | 0.44 | GoPro |
EV/EBITDA | -6.89 | -304.76 | Zepp Health |
Profit Margin (TTM) | -14.53% | -38.81% | GoPro |
Operating Margin (TTM) | -8.68% | -10.27% | GoPro |
Return on Equity | -76.81% | -28.32% | Zepp Health |
Return on Assets (TTM) | -8.03% | -5.10% | Zepp Health |
Free Cash Flow (TTM) | $-129.18M | $-25.88M | Zepp Health |
1-Year Return | 95.38% | 1,306.06% | Zepp Health |
Price-to-Sales Ratio (TTM) | 0.44 | 3.64 | GoPro |
Enterprise Value | $392.54M | $12.88B | Zepp Health |
EV/Revenue Ratio | 0.53 | 64.43 | GoPro |
Gross Profit Margin (TTM) | 35.81% | 36.18% | Zepp Health |
Revenue per Share (TTM) | $5 | $12 | Zepp Health |
Earnings per Share (Diluted) | $-0.67 | $-4.80 | GoPro |
Beta (Stock Volatility) | 1.52 | 1.35 | Zepp Health |
GoPro vs Zepp Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
GoPro | 9.96% | 27.00% | 78.87% | 191.95% | 234.21% | 130.91% |
Zepp Health | -2.60% | -7.22% | 6.72% | 1,841.42% | 1,178.24% | 1,516.72% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
GoPro | 95.38% | -49.50% | -41.07% | -92.14% | -92.90% | -92.90% |
Zepp Health | 1,306.06% | 683.78% | -8.73% | 1.93% | 1.93% | 1.93% |
News Based Sentiment: GoPro vs Zepp Health
GoPro
News based Sentiment: MIXED
GoPro experienced a significant, yet potentially unsustainable, stock price increase fueled by retail investor interest. While the company is making progress on cost control and has a positive outlook for future product launches, revenue is still declining, creating a mixed investment picture.
Zepp Health
News based Sentiment: POSITIVE
September was a strong month for Zepp Health, highlighted by impressive Q2 revenue growth and strategic moves like the Wild.AI acquisition and new brand ambassador. While a mid-month stock dip occurred, the overall narrative points to a successful turnaround and positive future outlook, making it a significant month for investors.
Performance & Financial Health Analysis: GoPro vs Zepp Health
Metric | GPRO | ZEPP |
---|---|---|
Market Information | ||
Market Cap | $327.44M | $740.17M |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 8,526,320 | 505,530 |
90 Day Avg. Volume | 8,725,050 | 609,043 |
Last Close | $2.54 | $46.40 |
52 Week Range | $0.40 - $2.63 | $2.12 - $55.99 |
% from 52W High | -3.42% | -17.13% |
All-Time High | $98.47 (Oct 06, 2014) | $81.00 (Feb 15, 2021) |
% from All-Time High | -97.42% | -42.72% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.18% | 0.46% |
Quarterly Earnings Growth | -0.18% | 0.46% |
Financial Health | ||
Profit Margin (TTM) | -0.15% | -0.39% |
Operating Margin (TTM) | -0.09% | -0.10% |
Return on Equity (TTM) | -0.77% | -0.28% |
Debt to Equity (MRQ) | 126.31 | 47.49 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $0.62 | $14.22 |
Cash per Share (MRQ) | $0.37 | $0.22 |
Operating Cash Flow (TTM) | $-75,777,000 | $-25,970,000 |
Levered Free Cash Flow (TTM) | $-23,788,250 | $-134,703,985 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: GoPro vs Zepp Health
Metric | GPRO | ZEPP |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 21.21 | -10.91 |
Forward P/E | 11.50 | -5,061.00 |
PEG Ratio | -0.31 | 0.44 |
Price to Sales (TTM) | 0.44 | 3.64 |
Price to Book (MRQ) | 3.34 | 3.56 |
Market Capitalization | ||
Market Capitalization | $327.44M | $740.17M |
Enterprise Value | $392.54M | $12.88B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.53 | 64.43 |
Enterprise to EBITDA | -6.89 | -304.76 |
Risk & Other Metrics | ||
Beta | 1.52 | 1.35 |
Book Value per Share (MRQ) | $0.62 | $14.22 |
Financial Statements Comparison: GoPro vs Zepp Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | GPRO | ZEPP |
---|---|---|
Revenue/Sales | $134.31M | $38.54M |
Cost of Goods Sold | $91.16M | $24.18M |
Gross Profit | $43.15M | $14.36M |
Research & Development | $29.56M | $12.38M |
Operating Income (EBIT) | $-24.94M | $-18.38M |
EBITDA | $-22.27M | $-17.79M |
Pre-Tax Income | $-45.06M | $-19.27M |
Income Tax | $1.65M | $110,000 |
Net Income (Profit) | $-46.71M | $-19.74M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | GPRO | ZEPP |
---|---|---|
Cash & Equivalents | $58.57M | $76.43M |
Total Current Assets | $255.47M | $242.46M |
Total Current Liabilities | $309.11M | $212.34M |
Long-Term Debt | $13.91M | $71.16M |
Total Shareholders Equity | $97.92M | $232.04M |
Retained Earnings | $-744.74M | $8.88M |
Property, Plant & Equipment | $21.59M | $9.56M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | GPRO | ZEPP |
---|---|---|
Operating Cash Flow | $1.96M | $-14.63M |
Capital Expenditures | $-478,000 | $-2.92M |
Free Cash Flow | $8.27M | $-16.89M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | GPRO | ZEPP |
---|---|---|
Shares Short | 15.86M | 910,727 |
Short Ratio | 1.89 | 1.49 |
Short % of Float | 0.12% | 0.15% |
Average Daily Volume (10 Day) | 8,526,320 | 505,530 |
Average Daily Volume (90 Day) | 8,725,050 | 609,043 |
Shares Outstanding | 155.45M | 231.98M |
Float Shares | 75.48M | 108.71M |
% Held by Insiders | 0.11% | 0.06% |
% Held by Institutions | 0.39% | 0.30% |
Dividend Analysis & Yield Comparison: GoPro vs Zepp Health
Metric | GPRO | ZEPP |
---|---|---|
Last 12-Month Dividend | N/A | $0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | $0.00 |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | $0.00 |
Ex-Dividend Date | N/A | N/A |